DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity

Journal of Hepatology

Volumn 65, Issue 1, 2016, Pages 113-124

  Xie, Lanfeng ^a,b   Wang, Pi Xiao ^b,c   Zhang, Peng ^b,c   Zhang, Xiao Jing ^b   Zhao, Guang Nian ^b,c   Wang, Aibing ^d   Guo, Junhong ^b,c   Zhu, Xueyong ^b,c   Zhang, Qin ^a   Li, Hongliang ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

^d HUNAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

ASK1; Dickkopf 3; Hepatic steatosis; Inflammation; Insulin resistance

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; DICKKOPF 3 PROTEIN; GLYCOPROTEIN; INSULIN; PALMITIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; DISEASE PREDISPOSITION; GENE OVEREXPRESSION; GENETIC DISORDER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIVER CELL; METABOLIC DISORDER; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; LIVER;

ANIMALS; DIET, HIGH-FAT; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; LIVER; MAP KINASE KINASE KINASE 5; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84964812427     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.03.008     Document Type: Article

References (47)

1. R. Loomba, and A.J. Sanyal The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 10 2013 686 690
2. N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, K. Cusi, and et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55 2012 2005 2023
3. R. Loomba, F. Rao, L. Zhang, S. Khandrika, M.G. Ziegler, D.A. Brenner, and et al. Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins Gastroenterology 139 2010 836 845 845 e831
4. B. Van De Wier, G.H. Koek, A. Bast, and G.R. Haenen The potential of flavonoids in the treatment of non-alcoholic fatty liver disease Crit Rev Food Sci Nutr 2015 [Epub ahead of print]
5. V. Ratziu, S. Bellentani, H. Cortez-Pinto, C. Day, and G. Marchesini A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 2010 372 384
6. W.J. Nelson, and R. Nusse Convergence of Wnt, beta-catenin, and cadherin pathways Science 303 2004 1483 1487
7. S.E. Ross, N. Hemati, K.A. Longo, C.N. Bennett, P.C. Lucas, R.L. Erickson, and et al. Inhibition of adipogenesis by Wnt signaling Science 289 2000 950 953
8. K.A. Longo, W.S. Wright, S. Kang, I. Gerin, S.H. Chiang, P.C. Lucas, and et al. Wnt10b inhibits development of white and brown adipose tissues J Biol Chem 279 2004 35503 35509
9. S. Wang, K. Song, R. Srivastava, C. Dong, G.W. Go, N. Li, and et al. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a FASEB J 29 2015 3436 3445
10. J. Veeck, and E. Dahl Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3 Biochim Biophys Acta 1825 2012 18 28
11. F. Abarzua, M. Sakaguchi, M. Takaishi, Y. Nasu, K. Kurose, S. Ebara, and et al. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase Cancer Res 65 2005 9617 9622
12. J. Yu, Q. Tao, Y.Y. Cheng, K.Y. Lee, S.S. Ng, K.F. Cheung, and et al. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer Cancer 115 2009 49 60
13. J. Veeck, N. Bektas, A. Hartmann, G. Kristiansen, U. Heindrichs, R. Knuchel, and et al. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours Breast Cancer Res 10 2008 R82
14. J. Roman-Gomez, A. Jimenez-Velasco, X. Agirre, J.A. Castillejo, G. Navarro, M. Barrios, and et al. Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia Br J Cancer 91 2004 707 713
15. S.Y. Hsieh, P.S. Hsieh, C.T. Chiu, and W.Y. Chen Dickkopf-3/REIC functions as a suppressor gene of tumor growth Oncogene 23 2004 9183 9189
16. H. Sato, H. Suzuki, M. Toyota, M. Nojima, R. Maruyama, S. Sasaki, and et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors Carcinogenesis 28 2007 2459 2466
17. T. Tsuji, I. Nozaki, M. Miyazaki, M. Sakaguchi, H. Pu, Y. Hamazaki, and et al. Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas Biochem Biophys Res Commun 289 2001 257 263
18. R. Mallarino, O. Campas, J.A. Fritz, K.J. Burns, O.G. Weeks, M.P. Brenner, and et al. Closely related bird species demonstrate flexibility between beak morphology and underlying developmental programs Proc Natl Acad Sci U S A 109 2012 16222 16227
19. M. Papatriantafyllou, G. Moldenhauer, J. Ludwig, A. Tafuri, N. Garbi, G. Hollmann, and et al. Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance Proc Natl Acad Sci U S A 109 2012 1631 1636
20. M.W. Bao, Z. Cai, X.J. Zhang, L. Li, X. Liu, N. Wan, and et al. Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction Basic Res Cardiol 110 2015 25
21. Y. Zhang, Y. Liu, X.H. Zhu, X.D. Zhang, D.S. Jiang, Z.Y. Bian, and et al. Dickkopf-3 attenuates pressure overload-induced cardiac remodelling Cardiovasc Res 102 2014 35 45
22. L.H. Zhu, A. Wang, P. Luo, X. Wang, D.S. Jiang, W. Deng, and et al. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor alpha in mice J Hepatol 60 2014 1046 1054
23. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
24. X.A. Wang, R. Zhang, Z.G. She, X.F. Zhang, D.S. Jiang, T. Wang, and et al. Interferon regulatory factor 3 constrains IKKbeta/NF-kappaB signaling to alleviate hepatic steatosis and insulin resistance Hepatology 59 2014 870 885
25. X.A. Wang, R. Zhang, S. Zhang, S. Deng, D. Jiang, J. Zhong, and et al. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance Am J Physiol Endocrinol Metab 305 2013 E485 E495
26. D. Gao, S. Nong, X. Huang, Y. Lu, H. Zhao, Y. Lin, and et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways J Biol Chem 285 2010 29965 29973
27. P. Gual, Y. Le Marchand-Brustel, and J.F. Tanti Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 87 2005 99 109
28. R.G. Baker, M.S. Hayden, and S. Ghosh NF-kappaB, inflammation, and metabolic disease Cell Metab 13 2011 11 22
29. A.J. Muslin MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets Clin Sci (Lond) 115 2008 203 218
30. R. Hayakawa, T. Hayakawa, K. Takeda, and H. Ichijo Therapeutic targets in the ASK1-dependent stress signaling pathways Proc Jpn Acad Ser B Phys Biol Sci 88 2012 434 453
31. M. Mouzaki, and R. Bandsma Targeting the gut microbiota for the treatment of non-alcoholic fatty liver disease Curr Drug Targets 16 2015 1324 1331
32. Y. Kawano, M. Kitaoka, Y. Hamada, M.M. Walker, J. Waxman, and R.M. Kypta Regulation of prostate cell growth and morphogenesis by Dickkopf-3 Oncogene 25 2006 6528 6537
33. B. Mao, W. Wu, Y. Li, D. Hoppe, P. Stannek, A. Glinka, and et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins Nature 411 2001 321 325
34. L. Zeng, W.J. Tang, J.J. Yin, and B.J. Zhou Signal transductions and nonalcoholic fatty liver: a mini-review Int J Clin Exp Med 7 2014 1624 1631
35. J.M. Kyriakis, and J. Avruch Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update Physiol Rev 92 2012 689 737
36. S. Chakrabarty, and L. Kondratick Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells Cancer Biol Ther 5 2006 189 197
37. I. Sinha-Hikim, A.P. Sinha-Hikim, R. Shen, H.J. Kim, S.W. French, N.D. Vaziri, and et al. A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice Exp Mol Pathol 91 2011 419 428
38. Y. Kodama, and D.A. Brenner C-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps Hepatology 49 2009 6 8
39. H. Nagai, T. Noguchi, K. Takeda, and H. Ichijo Pathophysiological roles of ASK1-MAP kinase signaling pathways J Biochem Mol Biol 40 2007 1 6
40. A. Matsuzawa, K. Saegusa, T. Noguchi, C. Sadamitsu, H. Nishitoh, S. Nagai, and et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity Nat Immunol 6 2005 587 592
41. K. Imoto, D. Kukidome, T. Nishikawa, T. Matsuhisa, K. Sonoda, K. Fujisawa, and et al. Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling Diabetes 55 2006 1197 1204
42. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
43. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
44. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M.F. White The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J Biol Chem 275 2000 9047 9054
45. Y. Kawarazaki, H. Ichijo, and I. Naguro Apoptosis signal-regulating kinase 1 as a therapeutic target Expert Opin Ther Targets 18 2014 651 664
46. M.C. Puckett, E.H. Goldman, L.M. Cockrell, B. Huang, A.L. Kasinski, Y. Du, and et al. Integration of apoptosis signal-regulating kinase 1-mediated stress signaling with the Akt/protein kinase B-IkappaB kinase cascade Mol Cell Biol 33 2013 2252 2259
47. Z. Gao, D. Hwang, F. Bataille, M. Lefevre, D. York, M.J. Quon, and et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex J Biol Chem 277 2002 48115 48121